Cybrexa Therapeutics Alternatives & Competitors
12 companies similar to Cybrexa Therapeutics — Changing the paradigm for cancer treatment through the development of antigen-in...
Companies similar to Cybrexa Therapeutics
Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...
Cambridge, United States
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
Boston, United States
Epitopea
Exploiting a new class of tumour specific antigens for cancer therapy
Montreal, Canada
Rival Readout
Competing with Cybrexa Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Bicycle Therapeutics
Precision-Guided Therapeutics
Cambridge, United Kingdom
TREOS THERAPEUTICS
Changing the paradigm of active cancer immunotherapy development
London, United Kingdom
ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, a...
ADC Therapeutics
Innovating Science. Inspiring Hope.
Lausanne, Switzerland
VRise Therapeutics, Inc.
A Precision Oncology Company
Cambridge, United States
Teon Therapeutics Inc.
Teon is a clinical company targeting metabolic signaling pathways and pioneering the devel...
Redwood City, United Stat...
Radionetics Oncology
Discovering and developing novel radiotherapeutics for the treatment of cancer.
San Diego, United States
Prelude Therapeutics
Precision Oncology, Redefined.
Wilmington, United States
About Cybrexa Therapeutics
Cybrexa Therapeutics, founded in 2017, is a promising clinical-stage oncology biotechnology company based in the United States. Specializing in the development of antigen-independent peptide drug conjugates, Cybrexa aims to shift the cancer treatment landscape with its innovative alphalex™ platform. This technology foc...
Development of novel peptide-drug conjugates, Antigen-independent tumor targeting, Phase 1 and Phase 2 clinical trials, Research and development in oncology, Enhancement of existing cancer therapies
Cancer patients, Oncologists, Healthcare providers specializing in oncology, Research institutions
Oncology, Clinical-stage, Peptide Drug Conjugates, Antigen-independent, Tumor Targeting, Drug Development, Cancer Treatment, PHLIP Peptides, Metastatic Cancer, Small Molecule Anti-cancer Agent, Clinical Trials, Management Team, Life Science, Proprietary Technology
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Cybrexa Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Cybrexa Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
